查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1712511

全球3D生物列印市場 - 2025-2033

Global 3D Bioprinting Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 165 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2024 年全球 3D 生物列印市場規模達到 34.5 億美元，預計到 2033 年將達到 302.8 億美元，在 2025-2033 年預測期內的複合年成長率為 24.2%。

3D 生物列印是一種使用數位模型創建3D結構的先進製造技術。它們應用於醫療保健、汽車和航太等行業。生物列印是 3D 列印的一個專業分支，涉及生物墨水的逐層沉積，結合活細胞和生物材料來創建類似組織的結構。該技術在再生醫學、藥物測試和器官移植研究方面具有潛力。它們共同徹底改變了產品設計和製造，提供了更高的精度、客製化和創新性。

市場動態：

駕駛員和約束裝置

組織工程和再生醫學的進展

全球 3D 生物列印市場受到組織工程和再生醫學進步的推動。生物列印技術能夠創建皮膚、軟骨和微型器官等複雜的組織結構，為藥物測試、疾病建模和器官移植提供了潛力。這些創新減少了動物試驗並加速了個人化治療。隨著研究機構和生物技術公司大力投資，對生物印表機和生物墨水的需求預計將會成長。

例如，2024年4月中國石油大學、浙江大學和特拉維夫大學合作，探索利用胜肽自組裝技術和3D列印技術開發複雜的生物結構和器官，為未來生物醫學應用奠定基礎。

監管和道德挑戰

由於對安全、同意和濫用的擔憂，全球 3D 生物列印市場面臨監管和道德挑戰。現有的監管架構往往不夠完善，導致商業化和臨床應用的延遲。這種不確定性可能會阻礙投資和創新，尤其是在醫療監管較為嚴格的地區，進而影響市場擴張。

目錄

第1章：市場介紹和範圍

  • 報告目標
  • 報告範圍和定義
  • 報告範圍

第2章：高階主管見解與關鍵要點

  • 市場亮點和戰略要點
  • 主要趨勢和未來預測
  • 按組件截取片段
  • 技術片段
  • 按應用程式截取的程式碼片段
  • 最終用戶的程式碼片段
  • 按地區分類

第3章：動態

  • 影響因素
    • 驅動程式
      • 組織工程和再生醫學的進展
      • 製藥和化妝品行業的應用日益廣泛
    • 限制
      • 監管和道德挑戰
      • 缺乏合格的專業人員
    • 機會
      • 個人化醫療和藥物測試的興起
    • 影響分析

第4章：戰略洞察與產業展望

  • 市場領導者和先驅者
    • 新興先鋒和傑出參與者
    • 擁有最大、最暢銷品牌的成熟領導者
    • 擁有成熟產品的市場領導者
  • CXO 觀點
  • 最新進展與突破
  • 案例研究/正在進行的研究
  • 監管和報銷情況
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 波特五力分析
  • 供應鏈分析
  • 專利分析
  • SWOT分析
  • 未滿足的需求和差距
  • 市場進入和擴張的推薦策略
  • 情境分析：最佳情況、基本情況和最壞情況預測
  • 定價分析和價格動態
  • 關鍵意見領袖

第5章：按組件

  • 3D印表機
  • 生物材料
  • 支架

第6章：3D生物列印市場（依技術）

  • 基於噴墨的生物列印
  • 磁浮
  • 基於注射器的生物列印
  • 基於雷射的生物列印
  • 其他

第7章：3D生物列印市場（按應用）

  • 靜脈穿刺協助
  • 醫療藥丸
  • 義肢和植入物
  • 牙科
  • 生物感測器
  • 消費者/個人產品測試
  • 生物墨水
  • 食品和動物產品

第 8 章：3D 生物列印市場（依最終用戶分類）

  • 研究機構和學術機構
  • 生物製藥公司
  • 醫院
  • 其他

第9章：3D 生物列印市場、區域市場分析與成長機會

  • 北美洲
    • 關鍵區域特定動態
      • 美國
      • 加拿大
      • 墨西哥
  • 歐洲
    • 關鍵區域特定動態
      • 德國
      • 英國
      • 法國
      • 西班牙
      • 義大利
      • 歐洲其他地區
  • 南美洲
    • 關鍵區域特定動態
      • 巴西
      • 阿根廷
      • 拉丁美洲其他地區
  • 亞太
    • 關鍵區域特定動態
      • 中國
      • 印度
      • 日本
      • 韓國
      • 亞太其他地區
  • 中東和非洲
    • 關鍵區域特定動態

第10章：競爭格局與市場定位

  • 競爭概況和主要市場參與者
  • 市佔率分析與定位矩陣
  • 策略夥伴關係、併購
  • 產品組合和創新的關鍵發展
  • 公司基準化分析

第 11 章：公司簡介

  • 3D Systems Corporation
    • 公司概況
    • 產品組合
      • 產品描述
      • 產品關鍵績效指標 (KPI)
      • 歷史和預測產品銷售
      • 產品銷售量
    • 財務概覽
      • 公司收入
      • 地區收入佔有率
      • 收入預測
    • 關鍵進展
      • 併購
      • 關鍵產品開發活動
      • 監管部門批准等
    • SWOT分析
  • EnvisionTEC GmbH
  • Stratasys Ltd
  • Cyfuse Biomedical KK
  • Cellink
  • Poietis
  • RegenHU SA

第 12 章：假設與研究方法

  • 資料收集方法
  • 數據三角測量
  • 預測技術
  • 數據驗證和確認

第 13 章：附錄

簡介目錄
Product Code: MD6751

The global 3D bioprinting market reached US$ 3.45 billion in 2024 and is expected to reach US$ 30.28 billion by 2033, growing at a CAGR of 24.2% during the forecast period 2025-2033.

3D bioprinting is are advanced manufacturing technologies that create three-dimensional structures using digital models. They are used in industries like healthcare, automotive, and aerospace. Bioprinting, a specialized branch of 3D printing, involves layer-by-layer deposition of bioinks, combining living cells and biomaterials to create tissue-like structures. This technology has potential in regenerative medicine, drug testing, and organ transplantation research. Together, they revolutionize product design and manufacturing, offering enhanced precision, customization, and innovation.

Market Dynamics: Drivers & Restraints

Advancements in Tissue Engineering and Regenerative Medicine

The global 3D bioprinting market is driven by advancements in tissue engineering and regenerative medicine. Bioprinting technologies enable the creation of complex tissue structures like skin, cartilage, and miniature organs, offering the potential for drug testing, disease modeling, and organ transplantation. These innovations reduce animal testing and accelerate personalized therapies. As research institutions and biotech companies invest heavily, demand for bioprinters and bioinks is expected to grow.

For instance, in April 2024 by China University of Petroleum, Zhejiang University, and Tel Aviv University explored the use of peptide self-assembly technology and 3D printing for developing complex biological structures and organs, laying the foundation for future biomedical applications.

Regulatory and Ethical Challenges

The global 3D bioprinting market faces regulatory and ethical challenges due to concerns about safety, consent, and misuse. Existing regulatory frameworks are often inadequate, leading to delays in commercialization and clinical adoption. This uncertainty can hinder investment and innovation, especially in regions with stricter medical regulations, affecting market expansion.

Segment Analysis

The global 3D bioprinting market is segmented based on component, technology, application, end-user, and region.

Component:

The 3D printers from the component segment are expected to dominate the 3D bioprinting market with the highest market share

3D printers are advanced devices that use additive manufacturing to create intricate biological structures by depositing bio-inks layer by layer. These bioinks, often containing living cells, biomaterials, and growth factors, mimic natural human tissues and organs. They are widely used in regenerative medicine, drug development, and disease modeling, enabling researchers to study cellular behavior and develop personalized treatments.

The global demand for 3D printers is driven by the growing demand for organ and tissue transplants, regenerative medicine investments, and personalized healthcare. Advancements in biomaterials and bioprinting technologies have improved tissue precision, expanding their use in clinical and research settings. Government support, regulatory developments, and partnerships between research institutes and biotech companies are also driving this growth.

For instance, in November 2024, University of Melbourne biomedical engineers developed a 3D bioprinter capable of creating structures that resemble various human body tissues, including soft brain tissue and harder materials like cartilage and bone.

Geographical Analysis

North America is expected to hold a significant position in the 3D bioprinting market with the highest market share

North America dominates the global 3D bioprinting market due to strong research, robust healthcare infrastructure, and early adoption of advanced technologies. The presence of biotech companies, research institutions, and universities in tissue engineering and regenerative medicine has accelerated bioprinting innovation. Government funding and regulatory frameworks, particularly in the U.S., promote 3D printing for medical applications like prosthetics, implants, and personalized healthcare solutions. The growing demand for organ transplantation alternatives and personalized medicine further drives the use of bioprinting technologies.

For instance, in June 2024, Tethon 3D, a Nebraska-based ceramic 3D printing specialist, launched the Bison Bio DLP 3D printer, a desktop-sized system designed for medical R&D applications. The system is compatible with Tethin 3D's Tethon LAP photoinitiator and Tethon GelMA hydrogel bioink, produced in partnership with Cell Bark Innovation, a biomaterial firm.

Competitive Landscape

The major global players in the 3D Bioprinting market include 3D Systems Corporation, EnvisionTEC GmbH, Stratasys Ltd, Cyfuse Biomedical KK, Cellink, Poietis, and RegenHU SA, among others.

Key Developments

  • In November 2024, SCTIMST developed India's first Indigenous patented bioink formulation for fabricating liver, kidney, pancreas, skin, brain, and heart tissues using advanced 3D bioprinting technology, using advanced 3D printing technology.

Why Purchase the Report?

  • Technological Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global 3D bioprinting market report delivers a detailed analysis with 70 key tables, more than 74 visually impactful figures, and 165 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Application & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Component
  • 2.4. Snippet by Technology
  • 2.5. Snippet by Application
  • 2.6. Snippet by End User
  • 2.7. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Advancements in Tissue Engineering and Regenerative Medicine
      • 3.1.1.2. Growing Adoption in Pharmaceutical and Cosmetic Industries
    • 3.1.2. Restraints
      • 3.1.2.1. Regulatory and Ethical Challenges
      • 3.1.2.2. Lack of Qualified Professionals
    • 3.1.3. Opportunity
      • 3.1.3.1. Rise in Personalized Medicine and Drug Testing
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with largest largest-selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. CXO Perspectives
  • 4.3. Latest Developments and Breakthroughs
  • 4.4. Case Studies/Ongoing Research
  • 4.5. Regulatory and Reimbursement Landscape
    • 4.5.1. North America
    • 4.5.2. Europe
    • 4.5.3. Asia Pacific
    • 4.5.4. Latin America
    • 4.5.5. Middle East & Africa
  • 4.6. Porter's Five Force Analysis
  • 4.7. Supply Chain Analysis
  • 4.8. Patent Analysis
  • 4.9. SWOT Analysis
  • 4.10. Unmet Needs and Gaps
  • 4.11. Recommended Strategies for Market Entry and Expansion
  • 4.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.13. Pricing Analysis and Price Dynamics
  • 4.14. Key Opinion Leaders

5. By Component

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 5.1.2. Market Attractiveness Index, By Component
  • 5.2. 3D Printers*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. Biomaterials
  • 5.4. Scaffolds

6. 3D Bioprinting Market, By Technology

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 6.1.2. Market Attractiveness Index, By Technology
  • 6.2. Inkjet-Based Bioprinting*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Magnetic Levitation
  • 6.4. Syringe-Based Bioprinting
  • 6.5. Laser-Based Bioprinting
  • 6.6. Others

7. 3D Bioprinting Market, By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.1.2. Market Attractiveness Index, By Application
  • 7.2. Venipuncture Assistance*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Medical Pills
  • 7.4. Prosthetics and Implants
  • 7.5. Dental
  • 7.6. Biosensors
  • 7.7. Consumer/Personal Product Testing
  • 7.8. Bioinks
  • 7.9. Food and Animal Products

8. 3D Bioprinting Market, By End User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 8.1.2. Market Attractiveness Index, By End User
  • 8.2. Research Organizations and Academic Institutes*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Biopharmaceutical Companies
  • 8.4. Hospitals
  • 8.5. Others

9. 3D Bioprinting Market, Regional Market Analysis and Growth Opportunities

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.7.1. U.S.
      • 9.2.7.2. Canada
      • 9.2.7.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.7.1. Germany
      • 9.3.7.2. U.K.
      • 9.3.7.3. France
      • 9.3.7.4. Spain
      • 9.3.7.5. Italy
      • 9.3.7.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.7.1. Brazil
      • 9.4.7.2. Argentina
      • 9.4.7.3. Rest of Latin America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.7.1. China
      • 9.5.7.2. India
      • 9.5.7.3. Japan
      • 9.5.7.4. South Korea
      • 9.5.7.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape and Market Positioning

  • 10.1. Competitive Overview and Key Market Players
  • 10.2. Market Share Analysis and Positioning Matrix
  • 10.3. Strategic Partnerships, Mergers & Acquisitions
  • 10.4. Key Developments in Product Portfolios and Innovations
  • 10.5. Company Benchmarking

11. Company Profiles

  • 11.1. 3D Systems Corporation*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio
      • 11.1.2.1. Product Description
      • 11.1.2.2. Product Key Performance Indicators (KPIs)
      • 11.1.2.3. Historic and Forecasted Product Sales
      • 11.1.2.4. Product Sales Volume
    • 11.1.3. Financial Overview
      • 11.1.3.1. Company Revenue's
      • 11.1.3.2. Geographical Revenue Shares
      • 11.1.3.3. Revenue Forecasts
    • 11.1.4. Key Developments
      • 11.1.4.1. Mergers & Acquisitions
      • 11.1.4.2. Key Product Development Activities
      • 11.1.4.3. Regulatory Approvals, etc.
    • 11.1.5. SWOT Analysis
  • 11.2. EnvisionTEC GmbH
  • 11.3. Stratasys Ltd
  • 11.4. Cyfuse Biomedical KK
  • 11.5. Cellink
  • 11.6. Poietis
  • 11.7. RegenHU SA

LIST NOT EXHAUSTIVE

12. Assumptions and Research Methodology

  • 12.1. Data Collection Methods
  • 12.2. Data Triangulation
  • 12.3. Forecasting Techniques
  • 12.4. Data Verification and Validation

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us